Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors

Recruiting N/A Interventional Study
Haplo-identical Transplantation Transplantation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
50 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Allogeneic hematopoietic stem cell transplantation (allo-HSC) is currently one of the only curative treatments for haematological malignancies with a poor prognosis, the realization of which presupposes the identification and availability of a compatible donor. In recent years, haploidentical transplants have been developed, a reliable alternative for patients who do not have 100% compatible donor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Identical haplo CSH donors ascending (parents) or descending (children) * Major identical haplo HSC donors * Haplo-identical HSC donors living in mainland France and cared for in the centers participating in the study * Haplo-identical HSC donors benefiting from Social Securit…
Contacts

Eolia Brissot

01 49 28 34 38

eolia.brissot@aphp.fr

CONTACT

Alice Polomeni

01 49 28 34 38

alice.polomeni@aphp.fr

CONTACT